| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CCKAR OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 FZD10 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 9.21e-23 | 884 | 133 | 40 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 5.36e-20 | 431 | 133 | 28 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CHRNA3 CHRNA4 CCKAR CHRNB4 OR8B3 OR8B8 ZACN OR2A12 OR13C9 OR10H3 OR13C2 FZD10 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.73e-19 | 1353 | 133 | 44 | GO:0004888 |
| GeneOntologyMolecularFunction | transporter activity | SLC37A1 ABCC1 SLC29A3 SLC22A25 SLC6A17 OCA2 STING1 ANO10 SLC7A7 SLC30A4 ABCA8 CHRNA3 CHRNA4 SLC22A12 ATP10D CHRNB4 SLC7A9 SLC22A9 ZACN ATP11B SLCO4C1 SLC44A5 SLC41A3 ABCA6 SERINC3 ATP11C CACNA1I SLC35E4 SLC45A1 ATP4A SLC4A11 | 2.78e-10 | 1289 | 133 | 31 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC37A1 ABCC1 SLC29A3 SLC22A25 SLC6A17 OCA2 STING1 ANO10 SLC7A7 SLC30A4 ABCA8 CHRNA3 CHRNA4 SLC22A12 CHRNB4 SLC7A9 SLC22A9 ZACN ATP11B SLCO4C1 SLC44A5 SLC41A3 ABCA6 SERINC3 CACNA1I SLC35E4 SLC45A1 ATP4A SLC4A11 | 7.18e-10 | 1180 | 133 | 29 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC37A1 ABCC1 SLC29A3 SLC22A25 SLC6A17 SLC30A4 ABCA8 SLC7A9 SLC22A9 SLCO4C1 SLC44A5 SLC41A3 ABCA6 SLC35E4 SLC45A1 ATP4A SLC4A11 | 1.95e-08 | 477 | 133 | 17 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC37A1 SLC22A25 SLC6A17 SLC30A4 SLC7A9 SLC22A9 SLCO4C1 SLC44A5 SLC41A3 SLC35E4 SLC45A1 SLC4A11 | 7.01e-07 | 296 | 133 | 12 | GO:0015291 |
| GeneOntologyMolecularFunction | odorant binding | 2.16e-06 | 127 | 133 | 8 | GO:0005549 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCC1 SLC22A25 ANO10 ABCA8 ATP10D SLC22A9 ATP11B ABCA6 ATP11C | 6.72e-06 | 196 | 133 | 9 | GO:0005319 |
| GeneOntologyMolecularFunction | antiporter activity | 3.90e-05 | 138 | 133 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 7.87e-05 | 13 | 133 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC37A1 ABCC1 SLC22A25 SLC7A7 SLC7A9 SLC22A9 SLCO4C1 SERINC3 SLC4A11 | 1.55e-04 | 293 | 133 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.83e-04 | 17 | 133 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | flippase activity | 1.83e-04 | 17 | 133 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.19e-04 | 18 | 133 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.69e-04 | 51 | 133 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | short-chain fatty acid transmembrane transporter activity | 4.35e-04 | 5 | 133 | 2 | GO:0015636 | |
| GeneOntologyMolecularFunction | prostaglandin E receptor activity | 4.35e-04 | 5 | 133 | 2 | GO:0004957 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 4.64e-04 | 23 | 133 | 3 | GO:0015245 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 4.64e-04 | 23 | 133 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | OCA2 STING1 ANO10 SLC30A4 CHRNA3 CHRNA4 CHRNB4 ZACN ATP11B SLC41A3 CACNA1I SLC45A1 ATP4A SLC4A11 | 8.37e-04 | 793 | 133 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 8.38e-04 | 28 | 133 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 9.05e-04 | 7 | 133 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.54e-03 | 9 | 133 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | STING1 ANO10 SLC30A4 CHRNA3 CHRNA4 CHRNB4 ZACN SLC41A3 CACNA1I SLC45A1 ATP4A SLC4A11 | 1.63e-03 | 664 | 133 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.75e-03 | 77 | 133 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.98e-03 | 133 | 133 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC1 RHOD ABCA8 ATP10D DNAH12 MDN1 ATP11B ABCA6 ATP11C ATP4A RAC1 RAC2 RAC3 | 2.02e-03 | 775 | 133 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.13e-03 | 343 | 133 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.30e-03 | 83 | 133 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 2.33e-03 | 11 | 133 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 2.47e-03 | 140 | 133 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.47e-03 | 140 | 133 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.66e-03 | 207 | 133 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.73e-03 | 208 | 133 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 2.78e-03 | 12 | 133 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 2.78e-03 | 12 | 133 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.82e-03 | 441 | 133 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.93e-03 | 43 | 133 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.66e-03 | 459 | 133 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 3.80e-03 | 14 | 133 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC1 RHOD ABCA8 ATP10D DNAH12 MDN1 ATP11B ABCA6 ATP11C ATP4A RAC1 RAC2 RAC3 | 3.99e-03 | 839 | 133 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC1 RHOD ABCA8 ATP10D DNAH12 MDN1 ATP11B ABCA6 ATP11C ATP4A RAC1 RAC2 RAC3 | 4.03e-03 | 840 | 133 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC1 RHOD ABCA8 ATP10D DNAH12 MDN1 ATP11B ABCA6 ATP11C ATP4A RAC1 RAC2 RAC3 | 4.03e-03 | 840 | 133 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.26e-03 | 49 | 133 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 4.37e-03 | 15 | 133 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 4.50e-03 | 100 | 133 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | floppase activity | 4.97e-03 | 16 | 133 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 4.97e-03 | 16 | 133 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.79e-03 | 171 | 133 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.11e-03 | 109 | 133 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 6.50e-03 | 57 | 133 | 3 | GO:1904315 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 NXNL2 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.37e-20 | 465 | 133 | 29 | GO:0007608 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CCKAR OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 FZD10 OR4D5 OR8D4 OR8B2 NOS2 PIK3R5 RAC1 RAC2 HTT OR5D13 OR1L4 | 2.27e-20 | 1395 | 133 | 45 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 2.46e-20 | 432 | 133 | 28 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 NXNL2 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.04e-19 | 547 | 133 | 30 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 5.32e-19 | 485 | 133 | 28 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 4.05e-18 | 524 | 133 | 28 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 6.15e-17 | 582 | 133 | 28 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception | USP53 OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 NXNL2 OR2B6 OR10T2 OR10X1 CHRNA4 OR8B3 OR8B8 CRYAA OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 USH2A OR5D13 OR1L4 | 4.92e-15 | 1072 | 133 | 34 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.44e-14 | 722 | 133 | 28 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC1 SLC22A25 ZMPSTE24 F2RL3 SLC6A17 OCA2 STING1 ANO10 SLC30A4 CHRNA3 CHRNA4 SLC22A12 ATP10D CCKAR CHRNB4 SLC22A9 ZACN ATP11B SLCO4C1 SLC41A3 ATP11C CACNA1I ATP4A SLC4A11 HTT | 2.10e-06 | 1374 | 133 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 4.16e-05 | 11 | 133 | 3 | GO:0035095 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC1 F2RL3 SLC6A17 OCA2 STING1 ANO10 SLC30A4 CHRNA3 CHRNA4 ATP10D CHRNB4 ZACN ATP11B SLC41A3 ATP11C CACNA1I ATP4A SLC4A11 HTT | 9.84e-05 | 1115 | 133 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | synaptic transmission involved in micturition | 1.23e-04 | 3 | 133 | 2 | GO:0060084 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC37A1 ABCC1 SLC22A25 SLC6A17 SLC7A7 SLC22A12 SLC7A9 SLC22A9 SLCO4C1 SERINC3 NOS2 SLC4A11 | 1.28e-04 | 515 | 133 | 12 | GO:0015711 |
| GeneOntologyCellularComponent | NADPH oxidase complex | 5.03e-06 | 18 | 137 | 4 | GO:0043020 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 9.51e-05 | 14 | 137 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 2.09e-04 | 18 | 137 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | PIGY SLC37A1 ZMPSTE24 OR2M2 OCA2 OR2M3 STING1 ATP10D STT3A TMEM33 ZDHHC22 DISP3 CYP7B1 ATP11C UGT2B28 UBIAD1 ALG6 RAC1 RAC2 RAC3 | 2.93e-04 | 1293 | 137 | 20 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | PIGY SLC37A1 ZMPSTE24 OR2M2 OCA2 OR2M3 STING1 ATP10D STT3A TMEM33 ZDHHC22 DISP3 CYP7B1 ATP11C UGT2B28 UBIAD1 ALG6 RAC1 RAC2 RAC3 | 3.11e-04 | 1299 | 137 | 20 | GO:0098827 |
| GeneOntologyCellularComponent | cholinergic synapse | 3.87e-04 | 22 | 137 | 3 | GO:0098981 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | PIGY SLC37A1 ZMPSTE24 OR2M2 OCA2 OR2M3 STING1 ATP10D STT3A TMEM33 ZDHHC22 DISP3 CYP7B1 ATP11C UGT2B28 UBIAD1 ALG6 RAC1 RAC2 RAC3 | 4.10e-04 | 1327 | 137 | 20 | GO:0042175 |
| GeneOntologyCellularComponent | transporter complex | CHRNA3 CHRNA4 ATP10D CHRNB4 WDR93 ZACN ATP11B CNTNAP2 ATP11C CACNA1I ATP4A | 1.01e-03 | 550 | 137 | 11 | GO:1990351 |
| Domain | GPCR_Rhodpsn_7TM | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CCKAR OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 5.65e-25 | 670 | 134 | 39 | IPR017452 |
| Domain | 7tm_1 | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CCKAR OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 8.28e-25 | 677 | 134 | 39 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CCKAR OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.27e-24 | 685 | 134 | 39 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CCKAR OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.75e-24 | 691 | 134 | 39 | PS50262 |
| Domain | GPCR_Rhodpsn | NPY2R HTR1D OR2L3 OR2M2 OR2B2 GPR33 OR5AU1 F2RL3 OR13C5 MLNR OR13C8 OR13C4 OR2G2 OXGR1 GPR84 OR2J3 OR10H4 OR2B3 TAAR5 OR6C68 OR8K3 OR2M3 PTGER2 OR2B6 PTGER4 OR10T2 OR10X1 CCKAR OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.85e-24 | 692 | 134 | 39 | IPR000276 |
| Domain | Olfact_rcpt | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 3.19e-20 | 393 | 134 | 28 | IPR000725 |
| Domain | RHO | 1.12e-05 | 20 | 134 | 4 | PS51420 | |
| Domain | 7TM_GPCR_Srsx | 1.62e-05 | 112 | 134 | 7 | SM01381 | |
| Domain | - | 2.02e-05 | 23 | 134 | 4 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 2.02e-05 | 23 | 134 | 4 | IPR027361 | |
| Domain | - | 7.79e-05 | 32 | 134 | 4 | 3.40.1110.10 | |
| Domain | - | 7.79e-05 | 32 | 134 | 4 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.12e-04 | 35 | 134 | 4 | IPR023299 | |
| Domain | P_typ_ATPase_c | 1.24e-04 | 14 | 134 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.24e-04 | 14 | 134 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.24e-04 | 14 | 134 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.24e-04 | 14 | 134 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.24e-04 | 14 | 134 | 3 | PF16209 | |
| Domain | P_typ_ATPase | 1.25e-04 | 36 | 134 | 4 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 1.25e-04 | 36 | 134 | 4 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 1.25e-04 | 36 | 134 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.39e-04 | 37 | 134 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.39e-04 | 37 | 134 | 4 | PF00122 | |
| Domain | Nicotinic_acetylcholine_rcpt | 1.89e-04 | 16 | 134 | 3 | IPR002394 | |
| Domain | MFS_1 | 2.30e-04 | 77 | 134 | 5 | PF07690 | |
| Domain | MFS | 2.30e-04 | 77 | 134 | 5 | IPR011701 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.00e-04 | 45 | 134 | 4 | IPR018000 | |
| Domain | Neur_chan_LBD | 3.56e-04 | 47 | 134 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 3.56e-04 | 47 | 134 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 3.56e-04 | 47 | 134 | 4 | IPR006029 | |
| Domain | - | 3.56e-04 | 47 | 134 | 4 | 2.70.170.10 | |
| Domain | Neur_channel | 3.56e-04 | 47 | 134 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 3.56e-04 | 47 | 134 | 4 | IPR006202 | |
| Domain | MFS | 1.09e-03 | 108 | 134 | 5 | PS50850 | |
| Domain | Prostanoid_rcpt | 1.39e-03 | 8 | 134 | 2 | IPR008365 | |
| Domain | HAD-like_dom | 2.51e-03 | 79 | 134 | 4 | IPR023214 | |
| Domain | MFS_dom | 2.81e-03 | 134 | 134 | 5 | IPR020846 | |
| Domain | ABC_A | 3.22e-03 | 12 | 134 | 2 | IPR026082 | |
| Domain | AA_permease_2 | 3.78e-03 | 13 | 134 | 2 | PF13520 | |
| Domain | SSD | 3.78e-03 | 13 | 134 | 2 | IPR000731 | |
| Domain | SSD | 3.78e-03 | 13 | 134 | 2 | PS50156 | |
| Domain | AA/rel_permease1 | 3.78e-03 | 13 | 134 | 2 | IPR002293 | |
| Domain | AAA+_ATPase | 3.83e-03 | 144 | 134 | 5 | IPR003593 | |
| Domain | AAA | 3.83e-03 | 144 | 134 | 5 | SM00382 | |
| Domain | F-box-like | 3.86e-03 | 44 | 134 | 3 | PF12937 | |
| Domain | Neur_chan_memb | 4.38e-03 | 46 | 134 | 3 | PF02932 | |
| Domain | ATPase_dyneun-rel_AAA | 4.39e-03 | 14 | 134 | 2 | IPR011704 | |
| Domain | AAA_5 | 4.39e-03 | 14 | 134 | 2 | PF07728 | |
| Domain | ABC_tran | 4.93e-03 | 48 | 134 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.93e-03 | 48 | 134 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.23e-03 | 49 | 134 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 5.53e-03 | 50 | 134 | 3 | IPR003439 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 3.32e-19 | 417 | 107 | 28 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR5D13 OR1L4 | 8.59e-18 | 389 | 107 | 26 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR6C68 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.82e-14 | 636 | 107 | 28 | M41834 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPY2R HTR1D OR2B2 F2RL3 MLNR OR2J3 OR2B3 PTGER2 OR2B6 PTGER4 CCKAR OR8B8 OR10H3 | 8.21e-08 | 260 | 107 | 13 | M39397 |
| Pathway | WP_GPCRS_ODORANT | 2.96e-06 | 157 | 107 | 9 | MM15872 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | NPY2R HTR1D F2RL3 MLNR TAAR5 PTGER2 PTGER4 CHRNA3 CHRNA4 CCKAR CHRNB4 | 6.79e-06 | 272 | 107 | 11 | M13380 |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.46e-05 | 7 | 107 | 3 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.46e-05 | 7 | 107 | 3 | MM15311 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY | 1.46e-05 | 7 | 107 | 3 | M47538 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.45e-05 | 9 | 107 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.45e-05 | 9 | 107 | 3 | MM15313 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY | 4.91e-05 | 10 | 107 | 3 | M47727 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 6.71e-05 | 11 | 107 | 3 | M883 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 8.46e-05 | 186 | 107 | 8 | MM15994 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 8.90e-05 | 12 | 107 | 3 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 8.90e-05 | 12 | 107 | 3 | MM15312 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 8.90e-05 | 12 | 107 | 3 | M39408 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.46e-04 | 14 | 107 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.81e-04 | 15 | 107 | 3 | MM14704 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.88e-04 | 70 | 107 | 5 | MM14984 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 SLC29A3 ANO10 SLC7A7 ABCA8 SLC22A12 ATP10D SLC7A9 ATP11B SLCO4C1 SLC44A5 ABCA6 ATP11C UNC79 ATP4A | 1.88e-04 | 681 | 107 | 15 | MM14985 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | NPY2R HTR1D F2RL3 MLNR OXGR1 TAAR5 PTGER2 PLPPR1 PTGER4 CCKAR | 2.03e-04 | 330 | 107 | 10 | M18334 |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 3.77e-04 | 19 | 107 | 3 | M47793 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 SLC29A3 ANO10 SLC7A7 ABCA8 SLC22A12 ATP10D SLC7A9 ATP11B SLCO4C1 SLC44A5 ABCA6 ATP11C UNC79 ATP4A | 4.31e-04 | 736 | 107 | 15 | M27287 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPY2R HTR1D F2RL3 MLNR OXGR1 TAAR5 PTGER2 PLPPR1 PTGER4 CCKAR FZD10 | 7.72e-04 | 463 | 107 | 11 | M507 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.95e-04 | 55 | 107 | 4 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 9.10e-04 | 57 | 107 | 4 | MM15643 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 9.67e-04 | 333 | 107 | 9 | MM14963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 9.73e-04 | 26 | 107 | 3 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 9.73e-04 | 26 | 107 | 3 | M47562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.21e-03 | 28 | 107 | 3 | M47655 | |
| Pathway | KEGG_COLORECTAL_CANCER | 1.25e-03 | 62 | 107 | 4 | M14631 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 1.49e-03 | 30 | 107 | 3 | M47718 | |
| Pubmed | OR2B2 OR5AU1 OR13C5 OR13C8 OR13C4 OR2G2 OR2J3 OR10H4 OR2B3 OR8K3 OR2M3 OR2B6 OR10T2 OR10X1 OR8B3 OR8B8 OR2A12 OR13C9 OR10H3 OR13C2 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 1.42e-19 | 541 | 138 | 25 | 14983052 | |
| Pubmed | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C8 OR2J3 OR10H4 OR6C68 OR8K3 OR2M3 OR2B6 OR10X1 OR8B3 OR8B8 OR2A12 OR10H3 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 4.85e-19 | 343 | 138 | 21 | 32295537 | |
| Pubmed | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C8 OR2J3 OR10H4 OR6C68 OR8K3 OR2M3 OR2B6 OR10X1 OR8B3 OR8B8 OR2A12 OR10H3 OR4D5 OR8D4 OR8B2 OR5D13 OR1L4 | 5.80e-19 | 346 | 138 | 21 | 14611657 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C8 OR2J3 OR10H4 OR6C68 OR8K3 OR2M3 OR2B6 OR10X1 OR8B3 OR8B8 OR2A12 OR10H3 OR4D5 OR8D4 OR8B2 OR1L4 | 7.76e-18 | 340 | 138 | 20 | 11875048 |
| Pubmed | OR2L3 OR2M2 OR2B2 OR5AU1 OR13C8 OR2J3 OR10H4 OR6C68 OR8K3 OR2M3 OR2B6 OR10X1 OR8B3 OR8B8 OR2A12 OR10H3 OR4D5 OR8D4 OR8B2 OR1L4 | 7.76e-18 | 340 | 138 | 20 | 11802173 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR2M2 OR5AU1 OR13C8 OR13C4 OR2J3 OR10H4 OR2B3 OR2M3 OR10X1 OR8B8 OR2A12 OR8B2 OR1L4 | 5.05e-12 | 219 | 138 | 13 | 12213199 |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 7.08e-10 | 12 | 138 | 5 | 12906860 | |
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 3.86e-09 | 16 | 138 | 5 | 19679677 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 16081809 | ||
| Pubmed | Signaling and cytoskeletal requirements in erythroblast enucleation. | 6.11e-08 | 3 | 138 | 3 | 22461493 | |
| Pubmed | rac, a novel ras-related family of proteins that are botulinum toxin substrates. | 6.11e-08 | 3 | 138 | 3 | 2674130 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 22123845 | ||
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 19628475 | ||
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 34943902 | ||
| Pubmed | 1.65e-07 | 13 | 138 | 4 | 16403838 | ||
| Pubmed | Ubiquilin-1 regulates nicotine-induced up-regulation of neuronal nicotinic acetylcholine receptors. | 2.44e-07 | 4 | 138 | 3 | 16091357 | |
| Pubmed | Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. | 6.08e-07 | 5 | 138 | 3 | 12663058 | |
| Pubmed | Specific association of nitric oxide synthase-2 with Rac isoforms in activated murine macrophages. | 6.08e-07 | 5 | 138 | 3 | 11457725 | |
| Pubmed | 6.08e-07 | 5 | 138 | 3 | 25031416 | ||
| Pubmed | Low ethanol concentration alters CHRNA5 RNA levels during early human development. | 6.08e-07 | 5 | 138 | 3 | 20438829 | |
| Pubmed | Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. | 6.08e-07 | 5 | 138 | 3 | 8987816 | |
| Pubmed | PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase. | 6.08e-07 | 5 | 138 | 3 | 22043008 | |
| Pubmed | Changes in Nicotinic Neurotransmission during Enteric Nervous System Development. | 1.21e-06 | 6 | 138 | 3 | 25948261 | |
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 8563774 | ||
| Pubmed | 2.11e-06 | 7 | 138 | 3 | 9009220 | ||
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 2.11e-06 | 7 | 138 | 3 | 1505988 | |
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 15964829 | ||
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 19098906 | ||
| Pubmed | Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task. | 3.37e-06 | 8 | 138 | 3 | 24598074 | |
| Pubmed | Functional interaction between Lypd6 and nicotinic acetylcholine receptors. | 3.37e-06 | 8 | 138 | 3 | 27344019 | |
| Pubmed | 3.37e-06 | 8 | 138 | 3 | 27048830 | ||
| Pubmed | 5.05e-06 | 9 | 138 | 3 | 8906617 | ||
| Pubmed | 5.22e-06 | 29 | 138 | 4 | 15071553 | ||
| Pubmed | 7.19e-06 | 10 | 138 | 3 | 15919184 | ||
| Pubmed | 7.19e-06 | 10 | 138 | 3 | 20736995 | ||
| Pubmed | Regulation of lymphatic-blood vessel separation by endothelial Rac1. | 7.19e-06 | 10 | 138 | 3 | 19906871 | |
| Pubmed | Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. | 9.85e-06 | 11 | 138 | 3 | 29791835 | |
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 12225896 | ||
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 18786395 | ||
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 1.13e-05 | 35 | 138 | 4 | 16939646 | |
| Pubmed | 1.31e-05 | 12 | 138 | 3 | 21914794 | ||
| Pubmed | 1.31e-05 | 12 | 138 | 3 | 20584212 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23884938 | ||
| Pubmed | Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts. | 1.56e-05 | 2 | 138 | 2 | 24980222 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 38345417 | ||
| Pubmed | Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4. | 1.56e-05 | 2 | 138 | 2 | 11450844 | |
| Pubmed | Rac-deficient cerebellar granule neurons die before they migrate to the internal granule layer. | 1.56e-05 | 2 | 138 | 2 | 36050459 | |
| Pubmed | Rac1 and Rac3 have opposite functions in Schwann cells during developmental myelination. | 1.56e-05 | 2 | 138 | 2 | 33812927 | |
| Pubmed | Identification of a Protein Network Driving Neuritogenesis of MGE-Derived GABAergic Interneurons. | 1.56e-05 | 2 | 138 | 2 | 28066185 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15504745 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22378897 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21343288 | ||
| Pubmed | Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2. | 1.56e-05 | 2 | 138 | 2 | 8250933 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 8078484 | ||
| Pubmed | Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo. | 1.56e-05 | 2 | 138 | 2 | 17175225 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15528331 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22306906 | ||
| Pubmed | Dispensable role of Rac1 and Rac3 after cochlear hair cell specification. | 1.56e-05 | 2 | 138 | 2 | 37204479 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19955208 | ||
| Pubmed | Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2. | 1.56e-05 | 2 | 138 | 2 | 26639895 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22993066 | ||
| Pubmed | Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. | 1.56e-05 | 2 | 138 | 2 | 14564009 | |
| Pubmed | 27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action. | 1.56e-05 | 2 | 138 | 2 | 33368618 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31369617 | ||
| Pubmed | Inhibition of Rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice. | 1.56e-05 | 2 | 138 | 2 | 21511011 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12027902 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21976675 | ||
| Pubmed | Prostaglandin E2 inhibits elastogenesis in the ductus arteriosus via EP4 signaling. | 1.56e-05 | 2 | 138 | 2 | 24146253 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21940819 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20551148 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 15275829 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16453125 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31402126 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12391220 | ||
| Pubmed | Cutting edge: Rac GTPases sensitize activated T cells to die via Fas. | 1.56e-05 | 2 | 138 | 2 | 17982024 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17996650 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26496249 | ||
| Pubmed | Binding interactions with the complementary subunit of nicotinic receptors. | 1.56e-05 | 2 | 138 | 2 | 23349463 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 11093764 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 32438662 | ||
| Pubmed | Tissue and zonal-specific expression of an olfactory receptor transgene. | 1.56e-05 | 2 | 138 | 2 | 9412503 | |
| Pubmed | Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production. | 1.56e-05 | 2 | 138 | 2 | 18250418 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33309799 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21949760 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 1689727 | ||
| Pubmed | Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors. | 1.56e-05 | 2 | 138 | 2 | 26051593 | |
| Pubmed | Rac1 and Rac2 control distinct events during antigen-stimulated mast cell exocytosis. | 1.56e-05 | 2 | 138 | 2 | 24399839 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 38864771 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23337716 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26582364 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25329458 | ||
| Pubmed | EP4 agonist inhibits lipopolysaccharide-induced mucus secretion in airway epithelial cells. | 1.56e-05 | 2 | 138 | 2 | 18254372 | |
| Pubmed | Rac2 is required for the formation of neutrophil extracellular traps. | 1.56e-05 | 2 | 138 | 2 | 21712395 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21111772 | ||
| Pubmed | Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity. | 1.56e-05 | 2 | 138 | 2 | 15920732 | |
| Pubmed | Potential therapeutic interventions via EP2/EP4 prostaglandin receptors. | 1.56e-05 | 2 | 138 | 2 | 22706114 | |
| Pubmed | Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. | 1.56e-05 | 2 | 138 | 2 | 18829529 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18086382 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20484658 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34529833 | ||
| Interaction | ARL6IP5 interactions | RHOD MYCBP2 STING1 SLC22A9 ZDHHC22 ZRANB1 ATP4A RAC1 RAC2 RAC3 | 1.41e-07 | 192 | 114 | 10 | int:ARL6IP5 |
| Interaction | FLVCR1 interactions | 1.45e-07 | 105 | 114 | 8 | int:FLVCR1 | |
| Interaction | LRRC8A interactions | 5.28e-07 | 85 | 114 | 7 | int:LRRC8A | |
| Interaction | SOWAHC interactions | 5.65e-07 | 29 | 114 | 5 | int:SOWAHC | |
| Interaction | DCBLD1 interactions | 8.01e-07 | 31 | 114 | 5 | int:DCBLD1 | |
| Interaction | SLC16A3 interactions | 8.23e-07 | 57 | 114 | 6 | int:SLC16A3 | |
| Interaction | SLC16A7 interactions | 9.45e-07 | 32 | 114 | 5 | int:SLC16A7 | |
| Interaction | ABCC1 interactions | 1.46e-06 | 142 | 114 | 8 | int:ABCC1 | |
| Interaction | ATP11A interactions | 1.50e-06 | 35 | 114 | 5 | int:ATP11A | |
| Interaction | MAP4K4 interactions | 1.83e-06 | 254 | 114 | 10 | int:MAP4K4 | |
| Interaction | IGSF3 interactions | 3.05e-06 | 71 | 114 | 6 | int:IGSF3 | |
| Interaction | JAG1 interactions | 3.38e-06 | 41 | 114 | 5 | int:JAG1 | |
| Interaction | C2CD2 interactions | 4.83e-06 | 44 | 114 | 5 | int:C2CD2 | |
| Interaction | ADD1 interactions | 5.85e-06 | 171 | 114 | 8 | int:ADD1 | |
| Interaction | SLC7A11 interactions | 7.08e-06 | 82 | 114 | 6 | int:SLC7A11 | |
| Interaction | CNNM3 interactions | 8.18e-06 | 179 | 114 | 8 | int:CNNM3 | |
| Interaction | BLTP1 interactions | 8.29e-06 | 49 | 114 | 5 | int:BLTP1 | |
| Interaction | CABLES1 interactions | 9.17e-06 | 50 | 114 | 5 | int:CABLES1 | |
| Interaction | SLC38A2 interactions | 9.64e-06 | 131 | 114 | 7 | int:SLC38A2 | |
| Interaction | ABCC5 interactions | 1.01e-05 | 51 | 114 | 5 | int:ABCC5 | |
| Interaction | SLC12A7 interactions | 1.01e-05 | 132 | 114 | 7 | int:SLC12A7 | |
| Interaction | SLC2A1 interactions | 1.14e-05 | 247 | 114 | 9 | int:SLC2A1 | |
| Interaction | VAMP3 interactions | RHOD TMEM237 STING1 CRYAA ATP11C ZRANB1 ATP4A RAC1 RAC2 RAC3 | 1.19e-05 | 314 | 114 | 10 | int:VAMP3 |
| Interaction | PLPPR3 interactions | 1.32e-05 | 26 | 114 | 4 | int:PLPPR3 | |
| Interaction | SLITRK4 interactions | 1.32e-05 | 26 | 114 | 4 | int:SLITRK4 | |
| Interaction | RAB23 interactions | 1.34e-05 | 54 | 114 | 5 | int:RAB23 | |
| Interaction | SLC35B2 interactions | 1.38e-05 | 92 | 114 | 6 | int:SLC35B2 | |
| Interaction | STT3B interactions | 1.52e-05 | 256 | 114 | 9 | int:STT3B | |
| Interaction | C2CD5 interactions | 1.66e-05 | 95 | 114 | 6 | int:C2CD5 | |
| Interaction | TBC1D5 interactions | 1.66e-05 | 95 | 114 | 6 | int:TBC1D5 | |
| Interaction | RAB11A interactions | ABCC1 DENND4A DNAJC13 SLC30A4 STT3A ATP11B SLCO4C1 XPO5 NAT10 SEMA4A UBIAD1 ZRANB1 ATP4A RAC1 RAC2 HTT | 1.75e-05 | 830 | 114 | 16 | int:RAB11A |
| Interaction | ADD3 interactions | 1.79e-05 | 144 | 114 | 7 | int:ADD3 | |
| Interaction | TMEM237 interactions | 1.97e-05 | 202 | 114 | 8 | int:TMEM237 | |
| Interaction | FLRT2 interactions | 2.07e-05 | 29 | 114 | 4 | int:FLRT2 | |
| Interaction | SLITRK5 interactions | 2.08e-05 | 59 | 114 | 5 | int:SLITRK5 | |
| Interaction | TMTC3 interactions | 2.22e-05 | 100 | 114 | 6 | int:TMTC3 | |
| Interaction | DOCK9 interactions | 2.45e-05 | 61 | 114 | 5 | int:DOCK9 | |
| Interaction | PLCB4 interactions | 3.09e-05 | 32 | 114 | 4 | int:PLCB4 | |
| Interaction | NECTIN2 interactions | 3.38e-05 | 159 | 114 | 7 | int:NECTIN2 | |
| Interaction | DHRS7B interactions | 3.62e-05 | 109 | 114 | 6 | int:DHRS7B | |
| Interaction | SUN1 interactions | 3.66e-05 | 161 | 114 | 7 | int:SUN1 | |
| Interaction | ADGRE5 interactions | 3.97e-05 | 163 | 114 | 7 | int:ADGRE5 | |
| Interaction | MFAP3 interactions | 4.16e-05 | 68 | 114 | 5 | int:MFAP3 | |
| Interaction | CD99 interactions | 4.16e-05 | 68 | 114 | 5 | int:CD99 | |
| Interaction | SLC20A2 interactions | 4.16e-05 | 68 | 114 | 5 | int:SLC20A2 | |
| Interaction | DIAPH2 interactions | 4.16e-05 | 68 | 114 | 5 | int:DIAPH2 | |
| Interaction | TMEM9 interactions | 4.39e-05 | 226 | 114 | 8 | int:TMEM9 | |
| Interaction | SLC39A14 interactions | 4.43e-05 | 113 | 114 | 6 | int:SLC39A14 | |
| Interaction | RASA3 interactions | 4.44e-05 | 35 | 114 | 4 | int:RASA3 | |
| Interaction | CLDND1 interactions | 4.79e-05 | 70 | 114 | 5 | int:CLDND1 | |
| Interaction | ZDHHC20 interactions | 4.97e-05 | 36 | 114 | 4 | int:ZDHHC20 | |
| Interaction | PCDH17 interactions | 4.97e-05 | 36 | 114 | 4 | int:PCDH17 | |
| Interaction | ADGRG6 interactions | 4.97e-05 | 36 | 114 | 4 | int:ADGRG6 | |
| Interaction | PIGN interactions | 5.13e-05 | 71 | 114 | 5 | int:PIGN | |
| Interaction | MUC13 interactions | 5.55e-05 | 37 | 114 | 4 | int:MUC13 | |
| Interaction | MPZL1 interactions | 5.65e-05 | 118 | 114 | 6 | int:MPZL1 | |
| Interaction | SLC9A1 interactions | 5.65e-05 | 118 | 114 | 6 | int:SLC9A1 | |
| Interaction | SLC11A2 interactions | 6.18e-05 | 38 | 114 | 4 | int:SLC11A2 | |
| Interaction | CPD interactions | 6.22e-05 | 175 | 114 | 7 | int:CPD | |
| Interaction | HLA-B interactions | 6.50e-05 | 239 | 114 | 8 | int:HLA-B | |
| Interaction | EMC3 interactions | 6.50e-05 | 121 | 114 | 6 | int:EMC3 | |
| Interaction | SLC29A1 interactions | 6.50e-05 | 121 | 114 | 6 | int:SLC29A1 | |
| Interaction | LSR interactions | 6.69e-05 | 177 | 114 | 7 | int:LSR | |
| Interaction | HACD3 interactions | 7.09e-05 | 242 | 114 | 8 | int:HACD3 | |
| Interaction | RELL1 interactions | 7.11e-05 | 76 | 114 | 5 | int:RELL1 | |
| Interaction | GNB4 interactions | 7.12e-05 | 123 | 114 | 6 | int:GNB4 | |
| Interaction | SLC6A6 interactions | 7.58e-05 | 40 | 114 | 4 | int:SLC6A6 | |
| Interaction | DIAPH3 interactions | 7.79e-05 | 125 | 114 | 6 | int:DIAPH3 | |
| Interaction | CDC42EP4 interactions | 8.06e-05 | 78 | 114 | 5 | int:CDC42EP4 | |
| Interaction | NECTIN3 interactions | 8.06e-05 | 78 | 114 | 5 | int:NECTIN3 | |
| Interaction | MACF1 interactions | 8.18e-05 | 247 | 114 | 8 | int:MACF1 | |
| Interaction | ANO6 interactions | 8.51e-05 | 127 | 114 | 6 | int:ANO6 | |
| Interaction | PPP1R9A interactions | 8.89e-05 | 128 | 114 | 6 | int:PPP1R9A | |
| Interaction | SLC12A4 interactions | 9.28e-05 | 129 | 114 | 6 | int:SLC12A4 | |
| Interaction | RAB11FIP5 interactions | 9.44e-05 | 187 | 114 | 7 | int:RAB11FIP5 | |
| Interaction | ARHGDIB interactions | 1.01e-04 | 43 | 114 | 4 | int:ARHGDIB | |
| Interaction | CLCC1 interactions | 1.04e-04 | 190 | 114 | 7 | int:CLCC1 | |
| Interaction | TRPM7 interactions | 1.05e-04 | 132 | 114 | 6 | int:TRPM7 | |
| Interaction | GOSR2 interactions | 1.05e-04 | 132 | 114 | 6 | int:GOSR2 | |
| Interaction | KRIT1 interactions | 1.11e-04 | 44 | 114 | 4 | int:KRIT1 | |
| Interaction | ROCK1 interactions | 1.11e-04 | 192 | 114 | 7 | int:ROCK1 | |
| Interaction | DAG1 interactions | 1.14e-04 | 134 | 114 | 6 | int:DAG1 | |
| Interaction | MTARC2 interactions | 1.21e-04 | 45 | 114 | 4 | int:MTARC2 | |
| Interaction | ADGRL1 interactions | 1.21e-04 | 85 | 114 | 5 | int:ADGRL1 | |
| Interaction | SLC12A2 interactions | 1.23e-04 | 195 | 114 | 7 | int:SLC12A2 | |
| Interaction | EHBP1 interactions | 1.29e-04 | 137 | 114 | 6 | int:EHBP1 | |
| Interaction | SLC7A1 interactions | 1.31e-04 | 197 | 114 | 7 | int:SLC7A1 | |
| Interaction | ITGA1 interactions | 1.32e-04 | 46 | 114 | 4 | int:ITGA1 | |
| Interaction | SLCO4A1 interactions | 1.32e-04 | 46 | 114 | 4 | int:SLCO4A1 | |
| Interaction | EMC1 interactions | 1.32e-04 | 418 | 114 | 10 | int:EMC1 | |
| Interaction | TNS3 interactions | 1.35e-04 | 87 | 114 | 5 | int:TNS3 | |
| Interaction | RALGAPA1 interactions | 1.35e-04 | 87 | 114 | 5 | int:RALGAPA1 | |
| Interaction | SLC16A1 interactions | 1.43e-04 | 200 | 114 | 7 | int:SLC16A1 | |
| Interaction | SLC20A1 interactions | 1.51e-04 | 89 | 114 | 5 | int:SLC20A1 | |
| Interaction | SLC35E4 interactions | 1.60e-04 | 19 | 114 | 3 | int:SLC35E4 | |
| Interaction | B2M interactions | 1.76e-04 | 92 | 114 | 5 | int:B2M | |
| Interaction | STEAP3 interactions | 1.83e-04 | 146 | 114 | 6 | int:STEAP3 | |
| Interaction | ERMP1 interactions | 1.90e-04 | 147 | 114 | 6 | int:ERMP1 | |
| Interaction | ANKLE2 interactions | 1.94e-04 | 210 | 114 | 7 | int:ANKLE2 | |
| Interaction | LMF1 interactions | 1.98e-04 | 51 | 114 | 4 | int:LMF1 | |
| Cytoband | 9q31.1 | 2.73e-09 | 41 | 138 | 6 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 3.93e-06 | 137 | 138 | 6 | chr9q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 2.61e-05 | 191 | 138 | 6 | chr11q24 | |
| Cytoband | 11q24.1 | 1.92e-04 | 37 | 138 | 3 | 11q24.1 | |
| Cytoband | 1q44 | 3.53e-04 | 110 | 138 | 4 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 6.25e-04 | 128 | 138 | 4 | chr1q44 | |
| GeneFamily | Solute carriers | SLC37A1 SLC29A3 SLC22A25 SLC6A17 SLC7A7 SLC30A4 SLC22A12 SLC7A9 SLC22A9 SLCO4C1 SLC44A5 SLC41A3 SLC35E4 SLC45A1 SLC4A11 | 1.68e-08 | 395 | 110 | 15 | 752 |
| GeneFamily | Olfactory receptors, family 2 | 2.89e-08 | 113 | 110 | 9 | 149 | |
| GeneFamily | Olfactory receptors, family 13 | 2.35e-07 | 23 | 110 | 5 | 162 | |
| GeneFamily | Rho family GTPases | 5.83e-06 | 20 | 110 | 4 | 390 | |
| GeneFamily | Olfactory receptors, family 8 | 1.17e-05 | 49 | 110 | 5 | 155 | |
| GeneFamily | ATPase phospholipid transporting | 9.45e-05 | 15 | 110 | 3 | 1210 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.16e-04 | 16 | 110 | 3 | 173 | |
| GeneFamily | Olfactory receptors, family 10 | 6.99e-04 | 66 | 110 | 4 | 157 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 1.28e-03 | 9 | 110 | 2 | 207 | |
| GeneFamily | Cyclins|F-boxes other | 1.71e-03 | 39 | 110 | 3 | 560 | |
| GeneFamily | ATP binding cassette subfamily A | 3.18e-03 | 14 | 110 | 2 | 805 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 178 | 137 | 7 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 178 | 137 | 7 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 178 | 137 | 7 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 8.28e-06 | 154 | 137 | 6 | 93145a1bc5712ae664690b03a9e00ce1f92cfc7e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-05 | 160 | 137 | 6 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-05 | 101 | 137 | 5 | 6523c314166dcf66c3ed13c02ca4b886b068e5b8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 137 | 6 | d687e6c3f9043f2574d072f815b8c2258f9dc7b5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 137 | 6 | 4f37854124d77ee64dcb40fd491eaed2ba389891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 137 | 6 | 0afba8707b847e5bdf6f38fe4379967631fe2240 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 177 | 137 | 6 | d445167dae956e641386f84ab3ae9f47c089e09a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.42e-05 | 186 | 137 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| Drug | 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane | 8.12e-07 | 4 | 135 | 3 | ctd:C569671 | |
| Drug | Anabasine | 8.12e-07 | 4 | 135 | 3 | ctd:D000691 | |
| Drug | N-(1,2,3,4-tetrahydro-1-naphthyl)-4-nitroaniline | 2.02e-06 | 5 | 135 | 3 | ctd:C524978 | |
| Drug | cisatracurium | 2.02e-06 | 5 | 135 | 3 | ctd:C101584 | |
| Drug | B258 | 4.02e-06 | 6 | 135 | 3 | CID000593690 | |
| Drug | decamethonium | 4.02e-06 | 6 | 135 | 3 | ctd:C033019 | |
| Drug | Atracurium | 7.01e-06 | 7 | 135 | 3 | ctd:D001279 | |
| Drug | mivacurium | 7.01e-06 | 7 | 135 | 3 | ctd:C049430 | |
| Drug | EPTC | 7.01e-06 | 7 | 135 | 3 | ctd:C036251 | |
| Drug | Dimethylphenylpiperazinium Iodide | 1.12e-05 | 8 | 135 | 3 | ctd:D004246 | |
| Drug | epibatidine | 1.12e-05 | 8 | 135 | 3 | ctd:C082748 | |
| Drug | fenoxycarb | 1.67e-05 | 9 | 135 | 3 | ctd:C052034 | |
| Drug | methylcarbamylcholine | 1.87e-05 | 27 | 135 | 4 | CID000004136 | |
| Drug | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 2.33e-05 | 96 | 135 | 6 | ctd:C080955 | |
| Drug | dihydrorhodamine 123 | 2.42e-05 | 58 | 135 | 5 | CID000105032 | |
| Drug | cytisine | 3.25e-05 | 11 | 135 | 3 | ctd:C004712 | |
| Drug | Dihydro-beta-Erythroidine | 3.25e-05 | 11 | 135 | 3 | ctd:D004079 | |
| Drug | Pancuronium | 3.25e-05 | 11 | 135 | 3 | ctd:D010197 | |
| Drug | rocuronium | 3.25e-05 | 11 | 135 | 3 | ctd:C061870 | |
| Drug | quinuclidine | 3.28e-05 | 31 | 135 | 4 | CID000007527 | |
| Drug | cytisine | 4.23e-05 | 33 | 135 | 4 | CID000010235 | |
| Drug | Vecuronium Bromide | 4.31e-05 | 12 | 135 | 3 | ctd:D014673 | |
| Drug | Te Al | 5.37e-05 | 35 | 135 | 4 | CID000168005 | |
| Drug | (+/-)-Epibatidine | 5.37e-05 | 35 | 135 | 4 | CID000001204 | |
| Drug | 16,16-Dimethylprostaglandin E2 | 5.58e-05 | 13 | 135 | 3 | ctd:D015064 | |
| Drug | Tubocurarine,d | 6.92e-05 | 72 | 135 | 5 | CID000001210 | |
| Drug | Varenicline | 7.07e-05 | 14 | 135 | 3 | ctd:D000068580 | |
| Drug | ZK110841 | 8.80e-05 | 15 | 135 | 3 | CID005311503 | |
| Drug | AY-22093 | 1.04e-04 | 3 | 135 | 2 | CID000193037 | |
| Drug | Misoprostol | 1.04e-04 | 3 | 135 | 2 | DB00929 | |
| Drug | GW627368X | 1.04e-04 | 3 | 135 | 2 | CID005312130 | |
| Drug | 1,2-bis-N-cytisinylethane | 1.04e-04 | 3 | 135 | 2 | ctd:C482518 | |
| Drug | Hexamethonium | 1.08e-04 | 16 | 135 | 3 | ctd:D018738 | |
| Disease | autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology) | 8.75e-08 | 3 | 132 | 3 | DOID:0080235 (implicated_via_orthology) | |
| Disease | smoking behavior, carbon monoxide exhalation measurement | 1.99e-05 | 2 | 132 | 2 | EFO_0004318, EFO_0006520 | |
| Disease | Generalized seizures | 9.32e-05 | 101 | 132 | 5 | C0234533 | |
| Disease | Clonic Seizures | 9.32e-05 | 101 | 132 | 5 | C0234535 | |
| Disease | Convulsive Seizures | 9.32e-05 | 101 | 132 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 9.32e-05 | 101 | 132 | 5 | C0751496 | |
| Disease | Non-epileptic convulsion | 9.32e-05 | 101 | 132 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 9.32e-05 | 101 | 132 | 5 | C0751123 | |
| Disease | Complex partial seizures | 9.32e-05 | 101 | 132 | 5 | C0149958 | |
| Disease | Single Seizure | 9.32e-05 | 101 | 132 | 5 | C0751110 | |
| Disease | Nonepileptic Seizures | 9.32e-05 | 101 | 132 | 5 | C3495874 | |
| Disease | Visual seizure | 9.32e-05 | 101 | 132 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 9.32e-05 | 101 | 132 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 9.32e-05 | 101 | 132 | 5 | C0422855 | |
| Disease | Gustatory seizure | 9.32e-05 | 101 | 132 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 9.32e-05 | 101 | 132 | 5 | C0422850 | |
| Disease | Olfactory seizure | 9.32e-05 | 101 | 132 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 9.32e-05 | 101 | 132 | 5 | C0422852 | |
| Disease | Generalized Absence Seizures | 9.32e-05 | 101 | 132 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 9.32e-05 | 101 | 132 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 9.32e-05 | 101 | 132 | 5 | C4317109 | |
| Disease | Absence Seizures | 9.77e-05 | 102 | 132 | 5 | C4316903 | |
| Disease | Convulsions | 9.77e-05 | 102 | 132 | 5 | C4048158 | |
| Disease | Tonic Seizures | 9.77e-05 | 102 | 132 | 5 | C0270844 | |
| Disease | Seizures, Focal | 1.07e-04 | 104 | 132 | 5 | C0751495 | |
| Disease | Myoclonic Seizures | 1.07e-04 | 104 | 132 | 5 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.07e-04 | 104 | 132 | 5 | C0494475 | |
| Disease | Physiological Sexual Disorders | 1.18e-04 | 4 | 132 | 2 | C0237873 | |
| Disease | Cis-4-decenoyl carnitine measurement | 1.97e-04 | 5 | 132 | 2 | EFO_0022091 | |
| Disease | decenoylcarnitine measurement | 1.97e-04 | 5 | 132 | 2 | EFO_0021803 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.53e-04 | 195 | 132 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | nicotine dependence (is_implicated_in) | 2.94e-04 | 6 | 132 | 2 | DOID:0050742 (is_implicated_in) | |
| Disease | nonanoylcarnitine (C9) measurement | 2.94e-04 | 6 | 132 | 2 | EFO_0800381 | |
| Disease | emphysema imaging measurement | 5.17e-04 | 146 | 132 | 5 | EFO_0007626 | |
| Disease | helping behavior measurement | 5.46e-04 | 8 | 132 | 2 | EFO_0008538 | |
| Disease | 5-hydroxylysine measurement | 5.46e-04 | 8 | 132 | 2 | EFO_0800002 | |
| Disease | cis-4-decenoylcarnitine (C10:1) measurement | 5.46e-04 | 8 | 132 | 2 | EFO_0800311 | |
| Disease | octanoylcarnitine measurement | 7.00e-04 | 9 | 132 | 2 | EFO_0021042 | |
| Disease | kidney disease (implicated_via_orthology) | 8.24e-04 | 41 | 132 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | estrogen measurement | 8.73e-04 | 10 | 132 | 2 | EFO_0011007 | |
| Disease | Alcohol Use Disorder | 1.01e-03 | 44 | 132 | 3 | C0001956 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 1.06e-03 | 11 | 132 | 2 | EFO_0801871 | |
| Disease | methionine sulfone measurement | 1.27e-03 | 12 | 132 | 2 | EFO_0800072 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.27e-03 | 12 | 132 | 2 | C1861063 | |
| Disease | decanoylcarnitine measurement | 1.27e-03 | 12 | 132 | 2 | EFO_0021039 | |
| Disease | Alcoholic Intoxication, Chronic | 1.34e-03 | 268 | 132 | 6 | C0001973 | |
| Disease | cognitive inhibition measurement | 1.47e-03 | 50 | 132 | 3 | EFO_0007969 | |
| Disease | glutaroyl carnitine measurement | 1.50e-03 | 13 | 132 | 2 | EFO_0021005 | |
| Disease | Manganese Poisoning | 1.74e-03 | 14 | 132 | 2 | C0677050 | |
| Disease | Depressive disorder | 1.96e-03 | 289 | 132 | 6 | C0011581 | |
| Disease | glycerol-3-phosphate measurement | 2.01e-03 | 15 | 132 | 2 | EFO_0010488 | |
| Disease | Withdrawal Symptoms | 2.26e-03 | 58 | 132 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.26e-03 | 58 | 132 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.26e-03 | 58 | 132 | 3 | C0038587 | |
| Disease | lung small cell carcinoma (is_marker_for) | 2.29e-03 | 16 | 132 | 2 | DOID:5409 (is_marker_for) | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 2.29e-03 | 16 | 132 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Disorder of eye | 2.70e-03 | 212 | 132 | 5 | C0015397 | |
| Disease | disease free survival | 2.90e-03 | 18 | 132 | 2 | EFO_0000409 | |
| Disease | Seizures | 3.04e-03 | 218 | 132 | 5 | C0036572 | |
| Disease | eye colour measurement | 3.04e-03 | 218 | 132 | 5 | EFO_0009764 | |
| Disease | skin pigmentation measurement | 3.40e-03 | 137 | 132 | 4 | EFO_0007009 | |
| Disease | Alcohol abuse | 3.40e-03 | 67 | 132 | 3 | C0085762 | |
| Disease | metabolite measurement | 3.79e-03 | 560 | 132 | 8 | EFO_0004725 | |
| Disease | nose morphology measurement, mouth morphology measurement | 3.94e-03 | 21 | 132 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | Liver diseases | 4.17e-03 | 72 | 132 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 4.17e-03 | 72 | 132 | 3 | C0086565 | |
| Disease | pentachlorophenol measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022071 | |
| Disease | parathion measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022070 | |
| Disease | potassium chromate measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022067 | |
| Disease | methoxychlor measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022055 | |
| Disease | aldrin measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022054 | |
| Disease | dicofol measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022060 | |
| Disease | disulfoton measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022062 | |
| Disease | dieldrin measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022061 | |
| Disease | endrin measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022064 | |
| Disease | endosulfan measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022063 | |
| Disease | heptachlor measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022066 | |
| Disease | ethion measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022056 | |
| Disease | diazinon measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0022058 | |
| Disease | environmental exposure measurement | 4.33e-03 | 73 | 132 | 3 | EFO_0008360 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTLLAILVFYLPSDC | 246 | P30926 | |
| LISCLTVLVFYLPSE | 256 | P43681 | |
| LVYILTSCSVFLSFF | 476 | Q9P2K9 | |
| PTETESTVFCLFVYL | 31 | Q86U02 | |
| SFLTVLVFYLPSDCG | 256 | P32297 | |
| FSISVRKYLPCFTFL | 421 | Q9Y672 | |
| LTTSFNTIFSPTLYL | 286 | Q49SQ1 | |
| ELSATDFLVCFIPYF | 1191 | Q8N139 | |
| SLYIFSFLSPKDLCA | 86 | Q008S8 | |
| PISFILLLSYTSSCV | 351 | P32238 | |
| LLLPFTTTYLCELGF | 516 | Q8TCP9 | |
| DPVFYLVCILTTSIA | 1296 | Q9P241 | |
| CSSPVFSRVLALEYF | 66 | O95741 | |
| STTIFLVFPFIAISC | 201 | Q8NG85 | |
| YESFSLPESVPLFCL | 221 | Q7Z401 | |
| FVVLCSILFSLYPDQ | 186 | Q04671 | |
| LSFIDFCYSSVITPK | 66 | Q15620 | |
| SYPQTDVFLICFSLV | 71 | P15153 | |
| DVFLICFSLVSPASY | 76 | P15153 | |
| SYPQTDVFLICFSLV | 71 | P60763 | |
| SYPQTDVFLICFSLV | 71 | P63000 | |
| DLLVNTLCLPFTLTY | 96 | P49146 | |
| LVSLPFVCLCLYFSL | 316 | Q9NW15 | |
| NVYLFSISPLSVLSC | 1151 | Q9NRD9 | |
| PCSLSQALTYFLDIT | 821 | P35228 | |
| LSFLDFCYSSVITPK | 66 | Q8NGM9 | |
| ALSFSETCYTLTIVP | 81 | Q8NGY0 | |
| ISFAPCILQTFLYLA | 91 | Q8NGT7 | |
| FFLTNLSILDLCYTT | 61 | O76000 | |
| LSFLDICYTTSSIPS | 66 | Q8NGS5 | |
| FFLTNLSLLDLCYTT | 61 | P58173 | |
| FLYRCFTSSVIPQLL | 71 | Q8NGZ5 | |
| VPVLSSYSDLVLFFL | 4611 | Q9NU22 | |
| LIPTISTCKFYLSFE | 231 | Q9Y231 | |
| IFFYISLSGSECFLL | 101 | Q96R28 | |
| IFFYTSLLGSECFLL | 101 | Q8NG83 | |
| NLSFLDFCYISVTIP | 66 | Q8NHC6 | |
| ITFAVCSLPFTIFAY | 271 | P43116 | |
| LCEYSTFILLFFSLS | 91 | P35408 | |
| SYLDSNCTIPLIFVL | 2486 | Q6ZR08 | |
| FETLNIPITYELFCS | 1926 | P50748 | |
| LFCLSASIIYPTTYV | 111 | Q96S97 | |
| LSFLDICYTTTSIPS | 66 | Q8NGS8 | |
| LSFLDICYTTTSIPS | 66 | Q8NGS9 | |
| LSFIDLCYSSVFTPK | 66 | Q8NGG8 | |
| SLLSIFVEPIYFSSI | 571 | P78563 | |
| FLATYRTFVPTACLL | 96 | Q3MIN7 | |
| DLLYCTLLQPFSVDT | 66 | Q9NQS5 | |
| LALLSYQFSTFSPSL | 776 | Q9H0A0 | |
| VLLGTSLTIPCYFID | 41 | P16112 | |
| YLFLCALSISEILFT | 61 | O60404 | |
| YLFLCTLSVSEILFT | 61 | Q8NGA5 | |
| ILSFSESCYTFVIIP | 66 | Q8NGX3 | |
| ALTCFSVLFLPKYST | 991 | Q9UII4 | |
| ACTDLLYLTSLPFLI | 76 | Q96P68 | |
| LALSTLNSCVDPFIY | 326 | Q96RI0 | |
| PLLLFILSSITYLTC | 111 | Q8TEZ7 | |
| YPDASVLLLCFDVTS | 86 | O00212 | |
| PLACYLVIGTSFILS | 401 | Q9ULW2 | |
| EFSLCLLFAKLVSYT | 331 | P57057 | |
| IQELSFSPYLISCTV | 1696 | P42858 | |
| LYTLLAEACLPAFVT | 3316 | Q4G0P3 | |
| RLPLTLVYCFAFLTE | 281 | Q8WUS8 | |
| SFCSIFSVLPYRDST | 346 | Q8TDN4 | |
| KPTSFAIICLSFSEY | 121 | P82251 | |
| RSCLSSLQFVSPLYF | 1696 | Q9P0X4 | |
| STCGAFYIPSVLLII | 201 | P28221 | |
| LLDFLTFALCAPYSE | 531 | O75165 | |
| ALFCIFTYLDTRTLL | 556 | Q8TF61 | |
| ILFYFNLLRCTSPSV | 91 | Q8NCS7 | |
| PCILLYISSFTTDFL | 1061 | Q9UHC6 | |
| YPFCSSIIFEITFTT | 181 | O75881 | |
| LSEYCLPSILRTLFD | 116 | Q5TBA9 | |
| FLHLPSESSLTCYEL | 4431 | Q8NDH2 | |
| LFEYDLLPFLSSTIS | 31 | P02489 | |
| LSLYIFSFLDPRSLC | 96 | Q8IX29 | |
| FSPYNEVLSFCLTVL | 396 | O75844 | |
| CITIYSSELFPTVLR | 451 | Q96S37 | |
| AFAPTILVYCSLRFL | 191 | Q6T423 | |
| YGILFSTLCTLPYSL | 671 | Q9Y2W3 | |
| VSVSFLVLSCFPSLF | 71 | Q16617 | |
| IELCTDIFPSVSLAY | 821 | P20648 | |
| IVCAFPYLLAFTTDS | 756 | Q5VVW2 | |
| VTTAYFFLPFLCLSI | 251 | O43193 | |
| LSFLDFCYSSITAPR | 66 | Q8NGN0 | |
| FFLSNLSLLDLCYTT | 61 | Q9GZK3 | |
| VCSLILTYFLLDLSF | 156 | Q8NGL4 | |
| LSFIDLCYSSVFTPK | 66 | Q96RD0 | |
| AVIVTPFLCTIFSYL | 206 | Q8NGR5 | |
| LSFLDVCYTSSSVPL | 66 | Q8NGS7 | |
| VCYTSSSVPLILASF | 71 | Q8NGS7 | |
| LSFLDICYTTTSIPS | 66 | Q8NGT0 | |
| FLDLCYTTSSIPQLL | 71 | O76001 | |
| TPFLVALCTFAVYVT | 556 | P33527 | |
| FFITSLIYPAICTNI | 316 | Q9BZD2 | |
| TYLDTLFCLTSIFHL | 111 | O14804 | |
| RLDPFTLYTLTLEAC | 4121 | O75445 | |
| TTTLFLYFACLLPTI | 361 | Q8NBS3 | |
| TCVLEYATPLQTLFA | 256 | Q86WV6 | |
| FDYFLTDLKCSLPAT | 206 | Q9NQ88 | |
| FLTTDLTYRCFVSFP | 76 | Q9H061 | |
| ALAPTFLIYCSLRFL | 191 | Q8IVM8 | |
| SLSFLDFCYSSTVVP | 116 | Q8NGC0 | |
| FNLLSCTLTILISYF | 256 | Q8NGC0 | |
| LPLFTSLLNTVCAYD | 246 | Q8IV36 | |
| CTFIELQDSYLLPIS | 151 | Q9H3S1 | |
| CVFLAPLFSSFTTIV | 116 | P46977 | |
| SLLSFYFPFCLLAKT | 491 | Q96GZ6 | |
| LLSLSSAAEPSILCY | 3351 | O75592 | |
| FTATCVPRFLYSIST | 71 | A6NDL8 | |
| SFITPLVLYCVLAAT | 66 | Q8TBJ4 | |
| AIPYLYCTFISLLVT | 146 | Q8NH51 | |
| ITDLYLFSCIISFSS | 221 | O94911 | |
| SFIKICFPFSSSIVL | 46 | Q8IZM0 | |
| VYLTLYNICFTSLPI | 911 | Q9Y2G3 | |
| YNICFTSLPILIYSL | 916 | Q9Y2G3 | |
| ICFTSLPILAYSLLE | 916 | Q8NB49 | |
| PFTEFVRYISTTALC | 176 | Q70EK8 | |
| LDPTALASFLYFTAL | 306 | Q96Q45 | |
| SSLICSFLSRIFYFP | 426 | I1YAP6 | |
| TSTFPLENVLSIFLY | 216 | P32971 | |
| FLPLLEFAYTSVLSF | 266 | O95625 | |
| APAYFLCISLVTFVL | 11 | Q8N966 | |
| LCVSVYVSLSLSSFP | 56 | Q96N35 | |
| YVSLSLSSFPCFSLT | 61 | Q96N35 | |
| SRDFTPLLCDFYTAL | 41 | Q5VZ03 | |
| LALLFYSTVLCTPHF | 81 | Q8WYR1 | |
| LISSSYDISFCLLSL | 146 | Q6ZQN7 | |
| LCTIFLVAVPLYSDT | 426 | Q9UM01 | |
| STASLCFYSLLLPIT | 36 | Q3MUY2 | |
| CVLTNVSALFPFVTY | 551 | Q9HAV4 | |
| FLPYLVFSILATHCT | 266 | Q9Y5Z9 | |
| LLSFTSAFYILSIIC | 206 | Q13530 | |
| PSLCLLILDSLSAFY | 141 | O43543 | |
| SSSCNPLLIYYFTIL | 286 | Q401N2 | |
| PICTYVFSLLVAFTT | 306 | O14863 | |
| STATFYFLLPSCLFA | 351 | Q6P2C0 | |
| LSFPFSIIFSTVLYC | 31 | Q5GH77 | |
| SSLFPYVVLACFLVR | 256 | Q9H1V8 | |
| DAVTLLYATSLPSFC | 216 | Q6ICL7 | |
| AALLNIPFVYSLCFT | 161 | Q9BY64 | |
| RLFTVYCSALFVLPL | 31 | P57088 | |
| ACYFLTDLVTFTLPA | 371 | Q9UGI0 | |
| LGQSIFYTTTCLLPF | 151 | Q9P2D8 | |
| FYTTTCLLPFLNDDI | 156 | Q9P2D8 | |
| TTALFTCYISSLFTP | 396 | Q86W24 |